Carenodes

New Episode! "Medicare Advantage 2026 Playbook: What Payers Won’t Tell Providers (and How to Win Anyway)"

Medicare Advantage 2026 isn’t something that’s about to happen—it’s already happening. In this episode, Alex Yarijanian breaks down what’s actually showing up in payer conversations right now, long before final rules are publ...

Medicare Advantage 2026 Playbook: What Payers Won’t Tell Providers (and How to Win Anyway) Medicare Advantage 2026 Playbook: What Payers Won’t Tell Providers (and How to Win Anyway) page for VBCA Podcast

New Episode! "Digital Health at a Crossroads: The Fallout from a $100M Adderall Fraud Scheme"

A federal jury has convicted the founders of Done, one of the fastest-growing telehealth companies in the stimulant-prescribing space, for orchestrating one of the largest Adderall distribution and fraud schemes in U.S. histo...

Digital Health at a Crossroads: The Fallout from a $100M Adderall Fraud Scheme A federal jury has convicted the founders of Done, one of the fastest-growing telehealth companies in the stimulant-prescribing space, for orchestrating one of the …

New Episode! "Medicare 2026 Fee Schedule: 5 Big Opportunities for Providers & Startups"

Medicare’s 2026 physician fee schedule is packed with change — but change means opportunity. In this episode of the VBCA Podcast, Alex Yarijanian breaks down the five biggest updates every provider and startup should know : S...

Medicare 2026 Fee Schedule: 5 Big Opportunities for Providers & Startups Medicare’s 2026 physician fee schedule is packed with change — but change means opportunity. In this episode of the VBCA Podcast, Alex Yarijanian breaks down the fi…

New Episode! "How to Win in Medicare Advantage 2026"

Welcome back to the Value-Based Care Advisory podcast! In this episode, host Alex Yarijanian delves into the significant updates and strategies for 2026 in the Medicare Advantage space. He covers essential news and policy cha...

How to Win in Medicare Advantage 2026 Welcome back to the Value-Based Care Advisory podcast! In this episode, host Alex Yarijanian delves into the significant updates and strategies for 2026 in the Medi…

New Episode! "Behind the Scenes of Power: Emotional Labor in Negotiation"

In this episode of the VBCA podcast, host Alex Yarijanian delves into the often overlooked yet crucial aspect of leadership: emotional labor. Discover how managing emotions plays a pivotal role in negotiations and leadership ...

Behind the Scenes of Power: Emotional Labor in Negotiation In this episode of the VBCA podcast, host Alex Yarijanian delves into the often overlooked yet crucial aspect of leadership: emotional labor. Discover how managing …

https://youtu.be/Jn-ilKjchc0?si=ZeQaVCyRiephUK-w
😰 Stress: The Silent Killer of Healthcare Leaders
It’s not just a buzzword—it’s a real threat.

👉 Watch this quick video that dives into how stress is draining the healthcare system from the top down.

🧠 Did you know 60%+ of healthcare leaders report being stressed?
Spoiler: It’s probably higher. And it’s not just affecting them—it ripples through entire organizations.

🧘‍♂️ Mindfulness isn’t just for yoga retreats.
In value-based care, it’s becoming a strategic advantage. It’s proven to modulate stress and sharpen leadership effectiveness.

🚨 With nearly half of physicians burned out, tackling stress at the leadership level isn’t optional—it’s survival.

🎯 So here's the question:
Are YOU using mindfulness as a leadership edge in your healthcare business?

The Mindful CEO Playbook Resilience, ROI & ResultsDiscover the proven neuroscience strategies transforming mindful leadership from concept into measurable healthcare outcomes. Alex Y...

New Episode! "Meditate Like a CEO: Real ROI from Mindful Leadership"

This podcast episode delves into the intricate relationship between mindfulness meditation and its profound implications for healthcare leadership. We explore how mindfulness practices not only enhance emotional well-being bu...

Meditate Like a CEO: Real ROI from Mindful Leadership This podcast episode delves into the intricate relationship between mindfulness meditation and its profound implications for healthcare leadership. We explore how m…

Turning Crisis into Hope — One Child, One Family at a Time

What happens when expert care meets real compassion?

Thanks to the PATH Technical Assistance Marketplace, Esteem Health and Carenodes are transforming lives across Central California — from a teen in crisis to foster families on the edge, they’re delivering not just services, but hope and healing. California Department of Health Care Services

-> A teen overcoming mental health and substance challenges
-> A foster family rediscovering connection and resilience

Learn how Carenodes is empowering organizations to change lives: https://capathsuccess.com/carenodes/



https://capathsuccess.com/carenodes/

The PATH Technical Assistance Marketplace is Empowering Central California Organizations to Serve Children, Youth, and Families – DHCS The PATH Technical Assistance Marketplace is Empowering Central California Organizations to Serve Children, Youth, and FamiliesRachel RittenhouseMay 1, 2025TA Marketplace The following Providing Access and Transforming Health (PATH) success stories describe Esteem Health’s experiences working with...

New Episode! "Managed Care Contracting for Health Tech Startups"

How Health Tech Startups Can Win at Managed Care Contracting: Insider Strategies for Scalable Payer Partnerships. This episode dives deep into the essentials of navigating managed care contracts as a health tech startup. Whet...

Managed Care Contracting for Health Tech Startups How Health Tech Startups Can Win at Managed Care Contracting: Insider Strategies for Scalable Payer Partnerships. This episode dives deep into the essentials of nav…

The Tragic Irony Behind Keytruda

It’s shocking how close we came to losing a potential cancer breakthrough. Keytruda—now a cash cow for Merck—spent far too long collecting dust in a forgotten pipeline. Let that sink in: a life-saving treatment was nearly tossed aside because a giant pharmaceutical company didn’t see its worth.

Worse yet? The public helped bankroll its revival. Government funds covered about a quarter of Keytruda’s development costs, fast-tracking the drug to approval. But who reaps the biggest rewards now? Merck. Meanwhile, patients often face enormous treatment bills.

It’s a bitter pill to swallow: so many people prayed for an effective cancer therapy, while the answer was just sitting on a shelf—overlooked by corporate priorities. Yet, here we are, witnessing huge profits for a company that almost let Keytruda fade away.

How many other life-saving treatments are we missing because of corporate blind spots?

The Surprising Journey of Keytruda Keytruda Backstory: You'll notice that Merck hasn't been involved so far. The early development was done primarily in academic institutions that were funded ...

https://www.youtube.com/watch?v=DNrXsZGlbxY
Millions of young people in the U.S. are struggling with mental health challenges, but many aren't receiving the care they need. 🌎 Discover the states leading the way—and those falling behind—in addressing youth mental health. Let's close the treatment gap and build a healthier future together! 🧠💙

Youth Mental Health Crisis The Untold Story Millions of young people in the U.S. are struggling with mental health challenges, but many aren't receiving the care they need. 🌎 Discover the states leadi...